SB465 Classifying xylazine as a schedule III controlled drug.
Classifying xylazine as a schedule III controlled drug.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
No direct financial impact; scheduling helps law enforcement target the most dangerous substances.
Your Community
Addresses a growing public health threat as xylazine-laced drugs cause severe injuries and deaths.
Your Freedom
Standard drug scheduling measure; xylazine has limited legitimate human use.
Status
Inexpedient to Legislate: Motion Adopted Voice Vote 04/23/2026 House Journal 11
Sponsor
William Gannon (R)
The Short Version
Would classify xylazine (an animal tranquilizer increasingly found in the illicit drug supply) as a Schedule III controlled substance. Xylazine is causing severe health effects including skin necrosis in people who unknowingly consume it with fentanyl.
Who's Behind This Bill?
Who Benefits
- ▲ Public health efforts targeting the opioid crisis
- ▲ Law enforcement combating dangerous drug combinations
- ▲ People who use drugs who face xylazine contamination risks
Who Pays the Price
- ▼ Veterinary practices that must comply with controlled substance handling for an animal medication
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.